Covid-19 vaccine-related adverse effects and perceptions in Haryana State of India
Datos Bibliográficos
| ID | 15799705 |
|---|---|
| Autores | Kamal Kamal (0000-0002-6110-4490, Kurukshetra University, autor de correspondencia), Themba Andile Msibi (Kurukshetra University) |
| Año | 2022 |
| Páginas | 1579-1610 |
| Fecha de publicación | 2022-06-15 |
| Peer Reviewed | Sí |
| Open Access | Sí |
| Tipo | ARTICLE |
| Revista | International Journal of Health Sciences (JOURNAL) |
| Identificadores de la revista | ISSN: 2550-696X • E-ISSN: 2550-6978 |
| Editorial | Universidad Tecnica de Manabi (PUBLISHER • EC) |
| DOI | 10.53730/ijhs.v6ns5.9008 |
| OpenAlex | W4283451326 |
| Idioma | EN |
| Referencias citadas | 6 |
Background: The focus of this study was on any COVID-19 vaccines adverse effects, as well as perceptions about the vaccines. Among many, Covishield Covid-19 (ChAdOx1 nCoV-19) and Covaxin COVID-19 (BBV152) vaccines are some of the vaccines which have reached their advanced stages. These two brands are very common in India, and the majority of the already vaccinated populations in India comes from these two brands. Methods: It was a quantitative systemic randomized retrospective cohort kind of a study where only healthcare practitioners were targeted, especially the prescribers. Survey questionnaire was used as a tool of collecting the data from the voluntarily recruited participants. Results: Among the participants, males (106) were more than females (98). Different healthcare professionals: 100 (49.0%) were Physician/doctors; 36 (17.6%) were Pharmacists; 27 (13.2%) were Nurses; 23 (11.3%) were Medical Lab. Technicians and 18 (8.8%) were others. 123 participants reported not been affected by any side effects after taking the COVID-19 vaccines, in contrast, 81 participants reported to have experienced adverse effects after had taken the vaccines. Conclusion: This study showed that post-vaccination, of both first and second dose, adverse effects were mild to moderate, non-serious and non-life threatening
Adverse effect · Coronavirus disease 2019 (COVID-19 · Disease · Family medicine · Health care · Vaccination · Diverse Scientific Research Studies · Medicine · SARS-CoV-2 and COVID-19 Research · Vaccine Coverage and Hesitancy · Immunology · Internal Medicine
The epidemiology and pathogenesis of coronavirus disease (Covid-19) outbreak
Sars-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Genomic characterisation and epidemiology of 2019 novel coronavirus
Covid-19 pandemic – an African perspective
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
Covid-19 Vaccines Safety Tracking (CoVaST)
| Velocidad de citación | historical |
|---|---|
| Altamente citado | No |